Orbis Holdings’s Novo Nordisk NVO Stock Holding History

Orbis Holdings’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-168,700	Closed	-$3.85M	–	87
2014 Q1	$3.85M	Buy	168,700 +71,080	+73%	+$1.51M	0.03%	71
2013 Q4	$1.8M	Sell	97,620 -3,915,650	-98%	-$68.2M	0.01%	70
2013 Q3	$67.9M	Buy	4,013,270 +2,151,690	+116%	+$36.2M	0.51%	41
2013 Q2	$28.8M	Buy	+1,861,580	New	+$31M	0.23%	48

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Orbis Holdings's NVO Position: Q2 2014 in Review

Orbis Holdings sold out of Novo Nordisk (NVO) in Q2 2014, closing a stake of 168,700 shares — an estimated $3.85M sold.

Orbis Holdings first reported a position in NVO in Q2 2013 and held it in 4 quarters. The position peaked at $67.9M in Q3 2013. 473 funds tracked by Wall St. Rank hold NVO as of Q2 2014.

Orbis Holdings reported no remaining Novo Nordisk position as of Q2 2014 after selling out during the quarter.
Orbis Holdings sold 168,700 Novo Nordisk shares in Q2 2014, an estimated $3.85M.
Orbis Holdings first reported a position in Novo Nordisk in Q2 2013 and held it in 4 quarters.
Orbis Holdings's Novo Nordisk position peaked at $67.9M in Q3 2013.
473 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2014.

Based on Orbis Holdings's 13F filing for Q2 2014, filed 14 Aug 2014.